Publications by authors named "Andreas Nechansky"

Claim this Profile
A
Application of Lectin Array Technology for Biobetter Characterization: Its Correlation with FcγRIII Binding and ADCC.
Markus Roucka, Klaus Zimmermann, Markus Fido, Andreas Nechansky

Microarrays (Basel)· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction of the hybcell-based compact sequencing technology and comparison to state-of-the-art methodologies for KRAS mutation detection.
Agnes Zopf, Roman Raim, Martin Danzer, Norbert Niklas, Rita Spilka, Andreas Nechansky

Biotechniques· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of ADCC activity with cytokine release induced by the stably expressed, glyco-engineered humanized Lewis Y-specific monoclonal antibody MB314.
Ralf Kircheis, Nicole Halanek, Iris Koller, Wolfgang Jost, Manfred Schuster, Andreas Nechansky

MAbs· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of therapeutics: a matter of efficacy and safety.
Andreas Nechansky, Ralf Kircheis

Expert Opin Drug Discov· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Response to: 'Impact of Glycosylation on Effector Functions of Therapeutic IgG' (Pharmaceuticals 2010, 3, 146-157).
Andreas Nechansky, Iris Koller, Ralf Kircheis

Pharmaceuticals (Basel)· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualification of a microfluidics-based electrophoretic method for impurity testing of monoclonal antibodies.
Bernhard Antes, Philipp Oberkleiner, Andreas Nechansky, Oliver H J Szolar

J Pharm Biomed Anal· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HAHA--nothing to laugh about. Measuring the immunogenicity (human anti-human antibody response) induced by humanized monoclonal antibodies applying ELISA and SPR technology.
Andreas Nechansky

J Pharm Biomed Anal· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Calibration Standards of Three Commercially Available Multiplex Kits for Human Cytokine Measurement to WHO Standards Reveals Striking Differences.
Andreas Nechansky, Susanne Grunt, Ivan M Roitt, Ralf Kircheis

Biomark Insights· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization of Rhesus monkeys with a SialylTn-mAb17-1A conjugate vaccine co-formulated with QS-21 induces a temporary systemic cytokine release and NK cytotoxicity against tumor cells.
Ralf Kircheis, Petra Siegl, Susanne Grunt, Nicole Halanek, Hans Loibner, Andreas Nechansky

Cancer Immunol Immunother· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of lysine clipping of a humanized Lewis-Y specific IgG antibody and its relation to Fc-mediated effector function.
Bernhard Antes, Sabine Amon, Andreas Rizzi, Susi Wiederkum, Manuela Kainer, Andreas Nechansky

J Chromatogr B Analyt Technol Biomed Life Sci· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compensation of endogenous IgG mediated inhibition of antibody-dependent cellular cytotoxicity by glyco-engineering of therapeutic antibodies.
Andreas Nechansky, Manfred Schuster, Wolfgang Jost, Petra Siegl, Susanne Wiederkum

Mol Immunol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunization of Rhesus monkeys with the conjugate vaccine IGN402 induces an IgG immune response against carbohydrate and protein antigens, and cancer cells.
Ralf Kircheis, Petra Vondru, Irene Zinöcker, Daniela Häring, Andreas Nechansky

Vaccine· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer immunotherapy.
Manfred Schuster, Andreas Nechansky, Ralf Kircheis

Biotechnol J· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SialylTn-mAb17-1A carbohydrate-protein conjugate vaccine: effect of coupling density and presentation of SialylTn.
Ralf Kircheis, Petra Vondru, Andreas Nechansky, Renate Ohler, Hans Loibner

Bioconjug Chem· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EpCAM is not a LAIR-1 ligand!
Andreas Nechansky, Ralf Kircheis

Cancer Biol Ther· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis